August 2025
LEADING IN NIH FUNDING AND UROLOGY CARE
The Department of Urology at Northwestern University Feinberg School of Medicine is proud to be ranked No. 1 in NIH funding in fiscal year 2024, generating over $7.1 million in NIH funding, supporting our mission to enhance urologic care and research. We are also honored to highlight that our program is home to the nation's leading urology principal investigator in funding, Sarki A. Abdulkadir, PhD, as well as Qi Cao, PhD, who ranks as the fourth highest-funded urology PI.*
“NIH funding allows us to accelerate and facilitate research to be translated to benefit patients, whether it’s in diagnostics, therapeutics or prevention.” – Sarki Abdulkadir, MD, PhD |
Published Studies Supported by the NIH
- Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial
- The Human Soluble NKG2D Ligand Differentially Impacts Tumorigenicity and Progression in Temporal and Model-Dependent Modes
- Impaired mitochondrial metabolism is a critical cancer vulnerability for MYC inhibitors
- EZH2 directly methylates PARP1 and regulates its activity in cancer
Additionally, the Urology Program at Northwestern Memorial Hospital is proud to be ranked among the 10 in the nation and to be the highest-ranked in Illinois for the 28th straight year by U.S. News & World Report, 2025 – 2026.
*Based on data from the NIH Reporter
